4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline CAS:183322-18-1

4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline has multiple applications, primarily in the pharmaceutical and research sectors. Its structural features allow it to interact with various biological targets, making it a candidate for drug discovery focusing on cancer therapy. Researchers investigate its efficacy against specific cancer cell lines, assessing its ability to inhibit tumor growth and induce apoptosis. Additionally, this compound's derivatives can be explored for anti-inflammatory treatments, where they may modulate immune responses or reduce inflammatory conditions. In microbiology, it could serve as a foundation for developing new antibiotics due to possible interactions with bacterial enzymes or receptors. Furthermore, in material science, compounds like 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline may find utility in synthesizing novel materials with desirable physical and chemical properties. Overall, its versatility makes it a significant subject of study across diverse scientific disciplines.